GROGAN DONNA ROY 4
4 · C4 Therapeutics, Inc. · Filed Aug 2, 2022
Insider Transaction Report
Form 4
GROGAN DONNA ROY
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-07-29+41,200→ 41,200 totalExercise: $9.64Exp: 2032-07-28→ Common Stock (41,200 underlying)
Footnotes (1)
- [F1]One-third of the shares underlying this option shall vest and become exercisable on July 29, 2023, with the remainder vesting in eight equal quarterly installments thereafter.